Marcee M. Maroney
Sales & Marketing at PULMONX CORPORATION
Profile
Marcee M.
Maroney is currently the Vice President-Marketing at Pulmonx Corp.
Prior to this, he worked as the Marketing Director at Angiotech BioMaterials Corp.
from 1998 to 2003, and as the Group Manager at Baxter Healthcare Corp.
in 2006.
From 2006 to 2015, he served as the Vice President-Clinical Affairs & Marketing at Carbylan Therapeutics, Inc. and later as the Vice President-Clinical Affairs at KalVista Pharmaceuticals,.
Inc. Maroney received his undergraduate and graduate degrees from San Jose State University.
Marcee M. Maroney active positions
| Companies | Position | Start |
|---|---|---|
| PULMONX CORPORATION | Sales & Marketing | - |
Former positions of Marcee M. Maroney
| Companies | Position | End |
|---|---|---|
| KALVISTA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2016-11-20 |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | 2006-01-31 |
Angiotech BioMaterials Corp.
 Angiotech BioMaterials Corp. BiotechnologyHealth Technology Angiotech BioMaterials Corp. develops tissue repair and regeneration technology. The company was founded by David J. Foster in June 1997 and is headquartered in Palo Alto, CA. | Sales & Marketing | 2002-12-31 |
Carbylan Therapeutics, Inc.
 Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Carbylan Therapeutics, Inc. engages in the development and market of medical devices and drug combination products to treat the pain associated with osteoarthritis. It offers Hydros Joint Therapy and Hydros-TA Joint Therapy, viscoelastic hyaluronan-based products designed to provide long term relief of the pain associated with osteoarthritis using a single intra-articular injection. The company was founded by Richard R. Orlandi, Albert Park, Glenn D. Prestwich and Richard K. Koehn in March 2004 and is headquartered in Palo Alto, CA. | Chief Tech/Sci/R&D Officer | - |
Training of Marcee M. Maroney
| San Jose State University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| KALVISTA PHARMACEUTICALS, INC. | Health Technology |
| PULMONX CORPORATION | Health Technology |
| Private companies | 3 |
|---|---|
Carbylan Therapeutics, Inc.
Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Carbylan Therapeutics, Inc. engages in the development and market of medical devices and drug combination products to treat the pain associated with osteoarthritis. It offers Hydros Joint Therapy and Hydros-TA Joint Therapy, viscoelastic hyaluronan-based products designed to provide long term relief of the pain associated with osteoarthritis using a single intra-articular injection. The company was founded by Richard R. Orlandi, Albert Park, Glenn D. Prestwich and Richard K. Koehn in March 2004 and is headquartered in Palo Alto, CA. | Health Technology |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Health Technology |
Angiotech BioMaterials Corp.
Angiotech BioMaterials Corp. BiotechnologyHealth Technology Angiotech BioMaterials Corp. develops tissue repair and regeneration technology. The company was founded by David J. Foster in June 1997 and is headquartered in Palo Alto, CA. | Health Technology |
- Stock Market
- Insiders
- Marcee M. Maroney
